Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Rank in Stocks #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Share Price
$0.106
Last synced: 2026-10-01
Market Cap
$767.67K
Change (1 day)
73.77%
Change (1 year)
-84.81%
Country
US
Trade Mosaic ImmunoEngineering Inc. (CPMV)

Category

P/B ratio for Mosaic ImmunoEngineering Inc. (CPMV)
P/B ratio as of 2026 TTM: 0
According to Mosaic ImmunoEngineering Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Mosaic ImmunoEngineering Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.5558 -
US
11.2791 -
US
4.0142 -
AU
7.082 -
NL
- -
CH